Viewing Study NCT07112833


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2025-12-26 @ 1:36 AM
Study NCT ID: NCT07112833
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-08
First Post: 2025-08-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)
Sponsor: Hebei Medical University Fourth Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module